Glenn Barney - Proteome Sciences Insider

PRM -- UK Stock  

GBp 3.67  0.08  2.13%

VP of Bus. Devel. - USA

Mr. Glenn Barney is Vice President Business Development, USA of Proteome Sciences PLC. Glenn brings over 25 years of sales and business development experience with global life sciences companies, with strong biomarker focus. He was formerly VP Business Development at NextGen Sciences Inc. and held senior positions at Decision Biomarkers and Parkin Elmer Inc
  VP Since 2011      
44 20 7043 2116  http://www.proteomics.com
Barney holds a BA in Biology from Boston University..

Management Efficiency

The company has return on total asset (ROA) of (20.17) % which means that it has lost $20.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (16.4) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 8.93 M in total debt. Proteome Sciences plc has Current Ratio of 0.38 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Found 2 records

VP Since

Ibrahim JalalHikma Pharmaceuticals PLC
2008
Andy BurrowsBTG plc
2017

Entity Summary

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company was incorporated in 1993 and is headquartered in London, the United Kingdom. Proteome Sciences operates under Diagnostics Research classification in UK and traded on London Stock Exchange. It employs 36 people.Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Hamilton House and employs 36 people.

Proteome Sciences plc Leadership Team

William Dawson, Director
Roger McDowell, Director
Christopher Pearce, Director
Ian Pike, Director, Ph.D
Richard Dennis, Executive
Malcolm Ward, Executive
Martin Diggle, Director
Jeremy Haigh, CEO
Josef Schwarz, Executive, MBA
Ursula Ney, Director, Ph.D
Glenn Barney, VP
Gee Chee, Director, Ph.D
Geoffrey Ellis, Director

Stock Performance Indicators

Current Sentiment - PRM

Proteome Sciences plc Investor Sentiment
Macroaxis portfolio users are evenly split in their perspective on investing in Proteome Sciences plc. What is your perspective on investing in Proteome Sciences plc? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
LULU   
Purchased over 90 shares of
3 hours ago
Traded for 106.18
EVK   
Purchased over 90 shares of
3 hours ago
Traded for 4.3
DPS   
Purchased over 90 shares of
3 hours ago
Traded for 120.36
ECL   
Sold over 90 shares of
3 hours ago
Traded for 144.71
DK   
Purchased over 90 shares of
3 hours ago
Traded for 52.08
Additionally take a look at Your Equity Center. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.